Answers · IP Strategy & Portfolio
How can a startup create an IP strategy, stage by stage?
Updated August 2026
The short answer
Build it in four stages keyed to funding: at pre-seed, decide what is protectable and document it; at seed, file provisional applications on the core inventions before any public disclosure; at Series A, convert the strong provisionals and file deliberately around the product; from Series B onward, manage what you hold as a portfolio with annual reviews. Each provisional buys 12 months of priority while you learn which inventions actually matter.
The strategy at every stage is the same question with a bigger budget: what would hurt most if a competitor had it, and is a patent, a trade secret, or speed the right way to protect it? Timing varies with the business context. Discussions with key suppliers, partners, or customers may justify filing before a Series A, because an early provisional can provide additional protection. Treat the sequence below as a starting plan and adjust it to the company's commercial milestones and disclosure risk.
Pre-seed: decide and document
Before money is spent on filings, get the hygiene right. Make sure every founder, employee, and contractor has signed IP assignment agreements, because missing assignments are among the most common diligence failures we see in early companies. Keep dated records of what was invented and when. Then run a first triage: list the things a competitor could copy, and sort them into patent candidates (technical inventions visible in the product), trade secret candidates (processes, data, and methods that stay behind the curtain), and things speed will protect better than paper.
This stage costs discipline rather than dollars, and it preserves every option for later.
Seed: the first filings
File provisional applications on the one to three inventions the company cannot afford to lose, and do it before any uncontrolled public disclosure: a launch, a demo day, a published paper. The US allows a 12-month grace period after your own disclosure, but most other countries allow none, so disclosing before filing typically forfeits foreign rights. Filing is legal work done by a registered patent attorney or agent; ipCG is a consultancy, not a law firm, and what we prepare at this stage is the disclosure document counsel drafts from.
Keep the count small and the descriptions deep. A provisional protects only what it actually teaches, and a thin provisional gives you a priority date for an invention you failed to describe.
Series A and beyond: from filings to a portfolio
With product-market signal and a real budget, convert the provisionals that still matter, let the rest lapse without regret, and start filing deliberately: improvements competitors would copy, design-arounds they would use as exits, and coverage in the jurisdictions where you will actually sell or manufacture. The 30-month PCT national-phase deadline is when foreign costs get real, so jurisdiction strategy belongs in the Series A conversation. This is also when invention capture should become systematic; a single facilitated session can yield a large batch of documented disclosures, which beats waiting for engineers to volunteer paperwork.
From Series B, run the portfolio like the asset it has become: annual mapping to products, pruning, competitive monitoring, and KPIs the board can read. Acquirers will eventually diligence all of it.
Related questions
How much should each stage cost?
Pre-seed is near zero beyond legal hygiene. At seed, published estimates commonly put a well-drafted provisional in the low thousands of dollars in attorney fees, with USPTO provisional fees in the low hundreds for small entities. Series A budgets scale with conversions and foreign decisions; our Patent Cost Calculator gives planning ranges.
Do investors actually care about patents?
Diligence asks, and published research has associated patent holdings with meaningfully higher odds of raising venture funding. What sophisticated investors care about is whether the filings cover the core technology they are buying into, rather than the count.
What about the things we should never patent?
A real startup IP strategy includes a trade secret track: training data, internal tooling, processes, and anything whose use a competitor could never detect. Patents publish; secrets do not. Sorting inventions between the tracks is half the value of the strategy.
We already launched without filing. Is it too late?
In the US you generally have a 12-month grace period from your own public disclosure, so there may still be a window, and improvements made since launch may be independently filable. Talk to a patent attorney promptly; the clock is unforgiving.
Right-size the strategy to your stage
Tell us your stage, your runway, and what you are building. A free discovery call is usually enough to sketch the next two stages of the plan.
Talk with Our TeamRelated
ipCapital Group is a consultancy, not a law firm, and nothing on this page is legal advice. Dollar figures on this page are typical market ranges for professional IP services, drawn from published sources and industry experience across a variety of providers. They are not an ipCG quote or rate card; every ipCG engagement is individually scoped and priced. See how our pricing works.